Periprocedural to 1-year safety and efficacy outcomes with the Pipeline Embolization Device with Shield technology for intracranial aneurysms: a prospective, post-market, multi-center study.

MLA

Rice, Hal, et al. “Periprocedural to 1-Year Safety and Efficacy Outcomes with the Pipeline Embolization Device with Shield Technology for Intracranial Aneurysms: A Prospective, Post-Market, Multi-Center Study.” Journal of NeuroInterventional Surgery, vol. 12, no. 11, Nov. 2020, pp. 1107–12. EBSCOhost, https://doi.org/10.1136/neurintsurg-2020-015943.

APA

Rice, H., Martínez Galdámez, M., Holtmannspötter, M., Spelle, L., Lagios, K., Ruggiero, M., Vega, P., Sonwalkar, H., Chapot, R., & Lamin, S. (2020). Periprocedural to 1-year safety and efficacy outcomes with the Pipeline Embolization Device with Shield technology for intracranial aneurysms: a prospective, post-market, multi-center study. Journal of NeuroInterventional Surgery, 12(11), 1107–1112. https://doi.org/10.1136/neurintsurg-2020-015943

Chicago

Rice, Hal, Mario Martínez Galdámez, Markus Holtmannspötter, Laurent Spelle, Konstantinos Lagios, Maria Ruggiero, Pedro Vega, Hemant Sonwalkar, René Chapot, and Saleh Lamin. 2020. “Periprocedural to 1-Year Safety and Efficacy Outcomes with the Pipeline Embolization Device with Shield Technology for Intracranial Aneurysms: A Prospective, Post-Market, Multi-Center Study.” Journal of NeuroInterventional Surgery 12 (11): 1107–12. doi:10.1136/neurintsurg-2020-015943.